Lexaria Bioscience Corp. (LEXX)
10.54
-0.38
(-3.44%)
USD |
NASDAQ |
Aug 24, 16:00
10.54
0.00 (0.00%)
Pre-Market: 20:00
Lexaria Bioscience Shareholders Equity (Quarterly) : 4.738M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.738M |
| February 28, 2026 | 6.602M |
| November 30, 2025 | 4.913M |
| August 31, 2025 | 2.990M |
| May 31, 2025 | 5.552M |
| February 28, 2025 | 7.145M |
| November 30, 2024 | 9.774M |
| August 31, 2024 | 8.036M |
| May 31, 2024 | 10.12M |
| February 29, 2024 | 6.521M |
| November 30, 2023 | 3.742M |
| August 31, 2023 | |
| May 31, 2023 | 4.396M |
| February 28, 2023 | 4.974M |
| November 30, 2022 | 6.262M |
| August 31, 2022 | 7.949M |
| May 31, 2022 | 9.184M |
| February 28, 2022 | 11.46M |
| November 30, 2021 | 11.68M |
| August 31, 2021 | 13.27M |
| May 31, 2021 | 10.34M |
| February 28, 2021 | 11.77M |
| November 30, 2020 | 1.878M |
| August 31, 2020 | 2.525M |
| May 31, 2020 | 3.187M |
| Date | Value |
|---|---|
| February 29, 2020 | 1.880M |
| November 30, 2019 | 2.526M |
| August 31, 2019 | 2.383M |
| May 31, 2019 | 3.179M |
| February 28, 2019 | 2.779M |
| November 30, 2018 | 3.414M |
| August 31, 2018 | 2.388M |
| May 31, 2018 | 2.637M |
| February 28, 2018 | 2.772M |
| November 30, 2017 | 2.402M |
| August 31, 2017 | 3.006M |
| May 31, 2017 | 3.265M |
| February 28, 2017 | 0.6912M |
| November 30, 2016 | 0.8067M |
| August 31, 2016 | 0.266M |
| May 31, 2016 | 0.1207M |
| February 29, 2016 | 0.265M |
| November 30, 2015 | 0.4638M |
| August 31, 2015 | 0.7724M |
| May 31, 2015 | 1.152M |
| February 28, 2015 | 1.145M |
| November 30, 2014 | 1.416M |
| October 31, 2014 | |
| July 31, 2014 | 3.550M |
| April 30, 2014 | 3.732M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | -8.655M |
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 11.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.781M |
| Total Liabilities (Quarterly) | 0.4371M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 10.60 |
| Net Debt Paydown Yield | 0.05% |